CONCEPT
This seminar will cover the important clinical and histopathologic features and variations for both common and unusual diseases of the female genital tract, underlining the most characteristic features. Case presentations will be used to highlight a practical approach to diagnosis. The overall aim is to refresh the attendee’s knowledge and to provide a conceptual framework that will allow the Pathologist to approach gynecologic specimens with confidence.
OBJECTIVES
At the completion of the seminar, participants will be able to:
- Understand differential diagnostic problems that are commonly encountered in gynecologic pathology and develop strategies to resolve them in routine practice.
- Improve the subtyping of gynecologic neoplasia, including endometrial and ovarian carcinoma, ovarian sex cord stromal tumors, and endocervical adenocarcinoma.
- Evaluate the utility, limitations and clinical significance of selected diagnostic and predictive biomarkers that are commonly utilized in gynecologic pathology.
- Summarize diagnostic criteria for precursor lesions for vulvar squamous cell carcinoma and distinguishing them from potential mimickers.
- Improve the grading and staging of endometrial carcinoma.
AUDIENCE
The audience for the Saturday Seminar is expected to consist of pathologists and trainees. Physicians in other specialties with an interest in gynecologic disorders are welcome.
The Seminar will begin Saturday, May 18th, 2024, at the Academic Learning and Teaching Center (ALTC) Room 3.304, at UT Health San Antonio in San Antonio, Texas
Registration, distribution of materials, and a light breakfast will begin at 7:30 a.m; the program will begin at 8:00 a.m. Lunch will also be provided. The program will conclude at 5:00 p.m.
The Seminar, Gynecologic Pathology: Practical Update and Diagnostic Issues, will be presented by Dr. Oluwole Fadare. Time will be available for questions from the audience at the end of each section. An electronic copy of the Annual Seminar materials will be provided to all attendees after the seminar.
78th Annual Seminar: Gynecologic Pathology: Practical Update and Diagnostic Issues
Saturday, May 18th, 2024
UT Health San Antonio, San Antonio, Texas
Academic Learning and Teaching Center, ALTC 3.304
Case presentations by Oluwole Fadare, M.D.
7:30 a.m. Registration & Continental Breakfast
8:00 a.m. Introduction by the Course Director
8:15 a.m. BLOCK1
- Clinically aggressive endometrial carcinomas: classics and newer entities (60 minutes)
- Practical Considerations for Key Biomarkers in Endometrial Carcinoma: HER2, DNA MMR and p53 (45 minutes).
10:00 a.m. Break
10:30 a.m. BLOCK2
- Issues related to grading and staging in endometrial carcinoma, including FIGO 2023 (75 minutes)
- Endometrial Pseudoneoplastic lesions and cancer mimics (30 minutes).
CME session ends
12:15 p.m. Lunch (provided)
CME session resumes
1:00 p.m. BLOCK3
- The Histotyping of Ovarian epithelial tumors: the Big 5 (60 minutes)
- Sex cord stromal tumors of the ovary: rare cases and problematic diagnostic scenarios (45 minutes)
2:45 p.m. Break
3:15 p.m. BLOCK4
- Endocervical adenocarcinoma: an update (60 minutes)
- Vulvar squamous cell carcinoma and putative precursor lesions: diagnostic considerations (45 minutes).
5:00 Adjournment
Oluwole Fadare, M.D. is the Chief of Anatomic Pathology for the University of California San Diego Health System, and a Professor of Pathology at the University of California San Diego School of Medicine. Dr. Fadare completed his residency in Anatomic and Clinical Pathology at Yale-New Haven Hospital, and fellowship in Gynecologic and Breast Pathology at Yale School of Medicine (New Haven, CT) under the tutelage of Dr. Fattaneh Tavassoli. Prior to his current academic appointment, he held positions as Associate Professor of Pathology and Ob/Gyn at Vanderbilt University (Nashville, TN), and as Director of Surgical Pathology at the former USAF Wilford Hall Medical Center (San Antonio, TX).
His long standing clinical and consultation practice is focused on gynecologic and breast cancers, and he has lectured around the world on these and related topics. He has published over 300 original articles, review articles, editorials, commentaries, and book chapters, primarily on gynecologic tract diseases. He has also authored or edited 5 books, including the popular Gynecologic and Obstetric Pathology, Volumes 1 and 2, whose second edition is under preparation. He contributed several chapters to the 5th edition of the World Health Organization Classification of Female Genital Tract tumors and has been part of consensus panels for practice guidelines published under the auspices of the International Society of Gynecologic Pathology (ISGyP), International Collaboration for Cancer Reporting (ICCR), College of American Pathologists (CAP), and the American Society of Clinical Pathologists (ASCP).
Dr. Fadare has been the recipient of several professional awards, including the 2018 Arthur Purdy Stout Prize for significant career achievements. He is the Editor-In-Chief of Annals of Diagnostic Pathology and serves on the editorial boards of several major pathology journals, including Modern Pathology, Human Pathology, American Journal of Clinical Pathology, International Journal of Gynecological Pathology, and Archives of Pathology and Laboratory Medicine, among others.
Dr. Fadare's research focuses primarily on the integration of morphological, phenotypic and molecular aspects of gynecologic and breast neoplasms to optimize diagnostic, prognostic and predictive patient care.
SEMINAR COURSE CO-DIRECTORS
Rosemarie Rodriguez, M.D.
President of SASP
Brooke Army Medical Center
San Antonio, Texas
rosemarie.rodriguez.mil@health.mil
Kenneth Thomas Hughes, M.D.
Secretary and Treasurer of SASP
Assistant Professor of Pathology
Univ. of Texas Health Science Center
San Antonio, Texas
hugheskt@uthscsa.edu
Christine Lee, M.D.
Vice President of SASP
Brooke Army Medical Center
San Antonio, Texas
christine.m.lee44.mil@health.mil
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint Providership of the College of American Pathologists and San Antonio Society of Pathologists. The College of American Pathologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The College of American Pathologists designates this live educational activity for a maximum of 7 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Disclaimer: The content of this CME activity does not necessarily reflect the view or policies of the College of American Pathologists.
